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Abstract: The functionality and viability of stored human red blood cells (RBCs) is an important 
clinical issue in transfusion. To systematically investigate changes in stored whole blood, the 
hematological properties of individual RBCs were quantified in blood samples stored for various 
periods with and without a preservation solution called CPDA-1. With 3-D quantitative phase imaging 
techniques, the optical measurements of the 3-D refractive index (RI) distributions and membrane 
fluctuations were done at the individual cell level. From the optical measurements, the morphological 
(volume, surface area and sphericity), biochemical (hemoglobin content and concentration), and 
mechanical parameters (dynamic membrane fluctuation) were simultaneously quantified to investigate 
the functionalities and their progressive alterations in stored RBCs. Our results show that the stored 
RBCs without CPDA-1 had a dramatic morphological transformation from discocytes to spherocytes 
within 2 weeks which was accompanied with significant decreases in cell deformability and cell surface 
area, and increases in sphericity. However, the stored RBCs with CPDA-1 maintained their morphology 
and deformability for up to 6 weeks. 
  
Introduction  
Blood storage is important for emergency transfusions during surgery and for the treatment of anemia. 
According to current protocols, human red blood cells (RBCs) can be stored up to 42 days at 1−6°C in 
a preservation solution (49). This solution, containing citrate, phosphate, dextrose, and adenosine 
(CPDA-1), prevents blood coagulation by chelating calcium and supplies the nutrient glucose and 
adenosine triphosphate (ATP) while maintaining a low pH. However, the results of clinical trials have 
shown progressive deteriorations in the functionalities of blood during blood banking/storage, and 
strong correlations between the stored period of blood and the mortality of transfused patients (32, 46, 
53). In clinical practice, it is generally recommended to use RBCs stored less than 14 days due to 
increase the risk of death and complications, although the shelf life of stored RBCs is much longer (26).  
The reasons for the increased mortality associated with blood transfusions and longer storage of 
RBCs are not well understood (28). However, previous studies have reported adverse alternations in the 
properties of RBCs over several weeks of storage; the hematological test showed noticeable increases 
in RDW (red cell distribution width) while other parameters including the mean corpuscular volume, 
mean corpuscular hemoglobin and mean corpuscular hemoglobin concentration were not changed 
significantly (1). In addition, the rate of morphological changes from discocyte to spherocyte gradually 
increases and becomes 50% at 2 weeks (6). The relative biochemical parameters including 2,3-DPG, 
potassium, pH, and ATP and nitric oxide levels are also changed toward unfavorable conditions for 
RBC viability (5). Elongation index tests (6, 57), optical tweezers techniques (14, 18), and 
ektacytometry experiments (15, 16, 54) have revealed that stored RBCs lose deformability as a function 
of the storage period. Recent studies have reported a decrease in the dynamic membrane fluctuations of 
stored RBCs (8) and a delay in passing through a narrow microfluidic channel as a result of large cell 
deformations (57) over time in storage.  
One of the important questions about stored RBCs is how these morphological and biochemical 
alternations from long storage periods affect the functions of RBCs. To address this question, systematic 
characterizations of individual RBCs should be quantified as a function of the storage time and at the 
individual cell level. Although previous studies on stored RBCs have significantly enhanced our 
understanding of storage lesions, none of them were able to investigate the morphological, biochemical, 
and mechanical parameters of individual RBCs simultaneously. Moreover, many of the previous 
methods only measured RBCs in the stored blood with CDPA-1 and thus not well suited to investigate 
the effects of the preservation solution on the properties of individual RBCs.  
Here, we systematically investigated the alterations of biophysical properties of individual RBCs as 
a function of the storage duration. With 3-D quantitative phase imaging (QPI) techniques, 3-D refractive 
index (RI) tomograms and dynamic membrane fluctuations of individual RBCs were simultaneously 
and quantitatively measured based on the principles of laser interferometry and optical diffraction 
tomography (29, 41). From the optical measurements, the morphological (volume, surface area and 
sphericity), biochemical (hemoglobin content and concentration), and mechanical parameters (dynamic 
membrane fluctuation) of individual RBCs were simultaneously quantified to investigate the 
functionalities and their progressive alterations in stored RBCs. The measurements were performed 
every few days up to 6 weeks to systematically investigate the alterations of these RBC parameters over 
time in storage. To investigate the effects of the preservation solution on the RBC parameters, we 
tracked two groups of RBCs: one stored in the absence and the other in the presence of a preservation 
solution known as CPDA-1. Our results show that the rate of morphological transformation from 
discocytes to spherocytes increased as the storage time increased, which was accompanied with 
increased membrane stiffness. For the stored RBCs without CPDA-1, all the RBCs became spherical 
shape within a week, whereas the storage agent CPDA-1 prevented the morphological transformation 
of the RBCs and maintained a healthy level of dynamic membrane fluctuations in the RBCs for up to 6 
weeks in storage.  
 
 
Results  
Morphological alterations in RBCs over time in storage 
To study how the morphologies of the stored RBCs changes over time in storage in the absence and 
presence of the preservation solution CPDA-1, the 3-D RI tomograms of individual stored RBCs were 
measured with cDOT at days 1, 5, 13, 20, 27, 34 and 41 of the storage period. The RBCs were stored 
at 4°C. Representative RI tomograms are shown in Fig. 1. The measured 3-D RI tomograms of RBCs 
without CPDA-1 showed significant morphological changes over time in storage (Fig. 1A&B). The 
RBCs underwent morphological transitions from discocytes to discocytes by day 5 of storage. Bumpy 
and specular structures emerged in the RBC membranes, and their dimple structures in the center 
disappeared. After 2 weeks, all the RBCs without CPDA-1 became spherocytes, that is, the RBCs had 
spherical shapes.  
In contrast, characteristic thin, doughnut-like shapes in the discocytes were still found in the RBCs 
stored with CPDA-1 up to 3 weeks of storage (Fig. 1C&D). After 20 days of storage, a portion of the 
spherocytes increased among the RBCs stored with CPDA-1. These morphological changes for both 
RBC groups over long storage periods were consistent with a previous report in which scanning electron 
microscopy was used (6). These morphological transitions can also be clearly seen in the rendered 
isosurface images of the reconstructed RI tomograms (Fig. 1 B&D). 
For a quantitative analysis, the morphological parameters including the cell volume, cell surface 
area, and sphericity were calculated from the measured 3-D RI tomograms (see Materials and Methods). 
The results are shown in Fig. 2. During 41 days of the storage period, the volumes of RBCs were 
maintained for both the control and the RBCs with CDPA-1 (Fig. 2A&B). The mean values for the 
cellular volumes of the stored RBCs without CPDA-1 at days 1, 5, 13, 20, 27, 34, and 41 of the storage 
period were 89.7 ± 11.9 (n = 37), 87.0 ± 15.6 (n = 39), 80.7 ± 7.4 (n = 39), 83.2 ± 9.8 (n = 36), 82.8 ± 
10.6 (n = 39), 89.9 ± 11.6 (n = 32), and 88.4 ± 9.9 fL (n = 34), and with CPDA-1 88.4 ± 12.2 (n = 43), 
87.2 ± 13.9 (n = 44), 85.9± 11.0 (n = 47), 83.3 ± 11.9 (n = 45), 86.0 ± 12.0 (n = 37), 83.2 ± 12.6 (n = 
43), and 82.5 ± 11.1 fL (n = 49), respectively. The unchanged cellular volume in the RBCs stored with 
CPDA-1 is consistent with a previous study using a complete blood machine, in which a large number 
of RBCs were averaged (1). 
The surface areas of the RBCs stored without CPDA-1 started to decrease around day 5, and almost 
all RBCs started to have similar small sizes after 13 days of storage (Fig. 2C). In contrast, the surface 
areas of the RBCs stored with CPDA-1 started to gradually decrease over a long time exhibiting large 
cell-to-cell variations. The mean values for the surface areas of RBCs without CPDA-1 at the 
corresponding storage periods were 152.7 ± 14.7, 127.7 ± 27.8, 98.5 ± 6.6, 100.2 ± 8.5, 99.5 ± 9.0, 
101.6 ± 9.1, and 101.0 ± 8.0 μm2, respectively. At day 5, the surface areas decreased by 16 % and further 
decreased by 33% at day 13. The mean values for the surface areas of the RBCs with CPDA-1 at the 
corresponding storage periods were 152.4 ± 13.3, 142.8 ± 20.1, 112.0 ± 23.5, 111.7 ± 17.2, 108.8 ± 23.7, 
106.8 ± 15.7, and 101.5 ± 16.0 μm2, respectively. At days 5 and 13, the surface area decreased by 6% 
and 26%, respectively. After day 13, the standard deviations for the cell surfaces area of the RBCs 
stored with CPDA-1 were 3 times larger than those for the control RBCs.  
To quantitatively analyze the morphological transition from healthy discocytes to abnormal 
spherocytes, the sphericity was calculated from the measured cell volume and surface area (see 
Materials and Methods). A sphericity of 1 corresponds to a perfect sphere and 0 to a flat surface. At 
day 1, the sphericities for RBCs stored with and without CPDA-1 do not show a significant difference. 
However, in the absence of CDPA-1, the sphericities of RBCs exhibit large variations at day 5. After 
day 13, in the absence of CPDA-1, all RBCs exhibit spherocytes. The mean values of sphericity for the 
RBCs stored without CPDA-1 at days 1, 5, 13, 20, 27, 34, and 41 of the storage period were 0.635 ± 
0.037, 0.774 ± 0.134, 0.953 ± 0.017, 0.956 ± 0.010, 0.959 ± 0.011, 0.953 ± 0.007, and 0.949 ± 0.007, 
respectively. In contrast, RBCs stored with CPDA-1 exhibited a prolonged transformation from 
discocytes to spherocytes. The mean values of sphericity for the RBCs stored with CPDA-1 at the 
corresponding storage periods were 0.631 ± 0.065, 0.677 ± 0.107, 0.836 ± 0.132, 0.843 ± 0.094, 0.872 
± 0.135, 0.893 ± 0.072, and 0.906 ± 0.012, respectively. 
Decreased deformability of stored RBCs  
To investigate the changes in the deformability of individual RBCs over the storage period, the dynamic 
membrane fluctuations of the cells were quantitatively measured. Dynamic membrane fluctuations 
manifest the deformability of RBC membranes, which is determined by the structures of the membrane 
cortex and the viscosity of the cell cytoplasm (43). The deformability of RBCs is strongly related to 
their ability to pass through small capillaries, and can be altered due to various pathophysiological 
conditions (9, 10, 13, 23, 36-38, 45, 48).  
The dynamic membrane fluctuations in RBCs were quantitatively and precisely measured using 
cDOT (24). The temporal full-field optical phase images of individual RBCs were measured with 
normal laser illumination, from which the mean and dynamic height maps of RBCs were obtained (see 
Materials and Methods). The representative mean height maps of individual RBCs at each tested 
storage day are presented in Fig. 3A1-A7 & C1-C7. Consistent with the results of the 3-D rendered 
isosurfaces (Fig. 1), the results of the mean cell shapes show that RBCs stored without CPDA-1 
underwent a fast morphological transformation from discocytes to spherical shapes; RBCs lost their 
characteristic biconcave shapes after day 5. In contrast, RBCs stored with CPDA-1 exhibited a 
significantly delayed transformation; biconcave shapes were still found at day 41 for many of the RBCs.  
To quantify the deformability of individual RBCs, the membrane fluctuations were calculated by 
spatially averaging the root-mean-squared (RMS) height displacements over the cell. The representative 
RMS height displacements maps of RBCs stored without and with CPDA-1 at various storage days are 
shown in Fig. 3B1-B7 and D1-D7, respectively. For RBCs stored without CPDA-1, the RMS height 
displacements of the spherocytes found in groups with a long storage period were significantly lower 
than those of the discocytes. However, the RMS height displacements of the RBCs stored with CDPA-
1 were not dramatically decreased. 
The mean membrane fluctuations of the RBCs at various days of the storage period are shown in 
Fig. 4. The membrane fluctuations of the RBCs stored without CPDA-1 rapidly decreased after 13 days 
of storage, whereas those of the RBCs stored with CPDA-1 gradually decreased and exhibited large 
cell-to-cell variations. The mean values for the membrane fluctuations of RBCs stored without CPDA-
1 were 46.0 ± 5.2, 45.6 ± 6.6, 32.1 ± 4.6, 30.0 ± 6.3, 33.7 ± 5.3, 30.2 ± 6.5 and 30.1 ± 4.9 nm, and in 
contrast with CPDA-1 46.8 ± 4.1, 47.6 ± 7.1, 41.0 ± 7.1, 42.1 ± 7.1, 38.2 ± 11.0, 39.1 ± 9.0 and 36.8 ± 
8.6 nm at days 1, 5, 13, 20, 27, 34, and 41 of the storage period, respectively. 
To further investigate the morphological alterations over the storage period, a correlation analysis 
was done between the fluctuations and sphericity. As shown in Fig. 5, the correlations between 
fluctuation levels and sphericity show similar trends for the RBCs with and without CPDA-1; the 
fluctuation level decreases as the sphericity increases. These correlations exhibited different alterations 
as the storage period increased for RBCs stored with or without CPDA-1 (see fitted 2-D Gaussian 
circles). By day 5 of the storage period without CPDA-1, the mean fluctuations of the RBCs gradually 
decreased as the sphericity increased from 0.6 to 1. After 2 weeks of storage, all the RBCs stored without 
CPDA-1 became highly spherical shapes, and their mean fluctuation levels were within 20−40 nm and 
significantly lower than the fluctuations of healthy discocytes at day 1. For RBCs stored with CPDA-1, 
the correlation clusters slowly moved toward the bottom right side in the scatter plot as the storage 
period increased; the clusters exhibited large deviations compared to that of the RBCs stored without 
CPDA-1. In addition, the results show that there exists an abrupt transition around a sphericity of 0.9 
regardless of the addition of CPDA-1. For RBCs with a sphericity smaller than 0.9, the fluctuation 
levels increased slowly as the sphericity increased at a constant rate (approx. a 20 nm decrease in 
fluctuations for a 0.5 increase in sphericity). However, the fluctuation levels abruptly decreased for 
RBCs with a sphericity higher than 0.9. This transition in the correlation implies that the substantial 
changes in the deformability are associated with spherocytosis. Our results clearly show that CPDA-1 
prevents spherocytosis and helps RBCs maintain a high deformability. 
 
Unchanged Hb content and concentration for stored RBCs   
To further investigate alternations in the cytoplasmic biochemical properties during the storage period, 
the hemoglobin (Hb) content and concentration in stored RBCs with or without CPDA-1 were 
quantified from the measured 3-D RI maps. Because the RBC cytoplasm is mainly composed of Hb 
and the RI of a RBC is linearly proportional to the Hb concentration, the total Hb content of individual 
RBCs was retrieved from the measured 2-D optical field images of the cells (2, 3, 11, 44). Then, the Hb 
concentrations of individual RBCs were calculated by dividing the Hb content by the cell volume (see 
Materials and Methods). 
Figure 6 shows the results for the Hb contents and concentrations. After 6 weeks of storage, there 
were no significant changes in the Hb content for both groups of RBCs stored with and without CPDA-
1 (Fig. 6A&B); the values for the Hb contents were within the reference range (28.5−33.5 pg) for 
healthy RBCs. The mean values for the Hb content of RBCs stored without CPDA-1 were 28.8 ± 3.6, 
30.5 ± 4.7, 29.9 ± 2.9, 30.0 ± 3.4, 29.8 ± 3.7, 29.4 ± 3.6 and 31.3 ± 3.8 and in contrast with CPDA-1 
28.6 ± 4.1, 29.8 ± 4.3, 28.8 ±3.3, 30.3 ± 3.8, 29.6 ± 3.2, 29.7 ± 4.0 and 30.9 ± 4.0 at days 1, 5, 13, 20, 
27, 34, and 41 of the storage period, respectively. These results are consistent with a recent work using 
digital holographic microscopy (33). 
The Hb concentrations for both groups of RBCs also did not significantly change over 41 days of 
storage (Fig. 6B&D). This can be easily understood due to the insignificant changes in both the Hb 
contents and cellular volumes. The mean values for the Hb concentrations of RBCs stored without 
CPDA-1 were 32.2 ± 1.9, 34.9 ± 4.0, 37.1 ± 1.9, 36.2 ± 2.2, 36.4 ± 2.4, 34.3 ± 1.9 and 35.4 ± 1.8 pg/dL, 
and with CPDA-1 were 34.8 ± 2.5, 34.6 ± 3.2, 34.5 ± 3.0, 35.4 ± 2.5, 34.7 ± 3.4, 35.7 ± 2.7 and 36.7 ± 
4.4 pg/dL, at days 1, 5, 13, 20, 27, 34, and 41 of the storage period, respectively. All the mean values 
for the Hb concentrations in the two groups were within the reference range for healthy RBCs (33−36 
g/dL). This result suggests that the cytoplasmic Hb proteins were not significantly degraded or removed 
during the 6 weeks of storage, despite the dramatic alterations in the morphological and mechanical 
properties. The unchanged Hb contents and concentrations in the RBCs stored with CPDA-1 were 
consistent with previous CBC measurements (1).  
Conclusion & Discussion 
In this paper, we investigated alterations in individual human RBCs during blood storage. With 3-D 
QPI techniques, the morphological (cellular volume, surface area, and sphericity), biochemical (Hb 
content, and Hb concentration) and mechanical properties (membrane fluctuation) of individual RBCs 
stored with and without CPDA-1 were systemically quantified.  
Our optical measurements showed no significant changes in cellular volumes, Hb contents and Hb 
concentrations during 6 weeks of storage for RBCs stored without CPDA-1. However, the surface areas 
of the RBCs significantly decreased during the first two weeks, showing sphericity values of unity. The 
morphologies of the RBCs dramatically transformed in less than 1 week of storage. In the absence of 
CPDA-1, 60% of the RBCs stored without CPDA-1 were a non-discocyte shape at day 5; after day 13, 
all the RBCs became spherical shapes. These results – the decrease in cell membrane area and the 
increase in sphericity – imply that spherocytosis is induced by vesiculation in the stored RBCs. This 
storage-induced spherocytosis seems to cause a significant decrease in cell deformability; membrane 
fluctuations in the RBCs decreased by 53% after two weeks of storage.  
In the RBCs stored in the presence of CPDA-1, the morphological transformation to spherocytosis 
was significantly delayed compared to the RBCs stored without CPDA-1. In the presence of CPDA-1, 
80% of the RBCs remained as discocytes at day 5. Furthermore, there was a large fraction of discocytes 
after 6 weeks of storage (38% of the RBCs had a sphericity less than 0.9), although the number of 
sphere-like RBCs gradually increased as the storage period increased. This decreasing trend in cell 
deformability is qualitatively consistent with a previous report (6), in which the averaged values of the 
deformation index of the RBCs were significantly reduced after two weeks of storage (approx. 39%). 
It is well known that CPDA-1 extends the survival days of stored RBCs by providing adenine to 
maintain cytoplasmic ATP levels (17, 49). Our results clearly show that distinct trends in stored RBCs 
- morphological transformation from discocytes to spherocytes as well as a decrease in membrane 
deformability – were considerably reduced in the presence of CPDA-1 at the individual cell level. This 
result agree with a previous work using a narrow micro channel mimicking microcirculation (27). In 
particular, the decreased amplitudes in dynamic membrane fluctuation decreases over storage time (Figs. 
4A-B) are consistent with those of a previous work in which cytoplasmic ATP was depleted chemically 
and metabolically (4, 7, 36, 47). More importantly, our results suggest the presence of sub-groups in 
RBCs exhibiting various responses to CPDA-1. For example, the sphericities and dynamic membrane 
fluctuations after two weeks of storage showed highly dispersed values ranging from healthy levels to 
severe spherocytes. This large cell-to-cell variations in the responses to CPDA-1 could be from various 
factors, including the different ages of the individual RBCs or various cellular levels of potassium and 
2,3-DPG in RBCs (5).  
Our results suggests measurements of sphericity can be exploited to address the expected duration 
of RBCs in clinic. Traditional CBC measurements do not provide information about sphericity or cell 
surface area. Hence, it remained challenging to expect the survival duration of RBCs in stored blood. 
Currently, reticulocyte count can be used for addressing the fraction of young RBCs. However, the 
fraction of old RBCs in blood cannot be measured. In the view of clinical hematology, the results 
presented in this work suggests that sphericity or surface area is strongly correlated with the viability 
of RBCs and can also be used as a proxy for the cell age of RBCs. In other words, measurements of cell 
sphericity may enable to provide information about the expected survival duration of RBCs. In 
particular, the sphericity higher than 0.9 or the membrane fluctuations of 35−40 nm or below could be 
used for criteria to identity inviable RBCs.  
In this paper, we presented the optical measurements for various parameters of stored RBCs and 
investigated the progressive alterations of these retrieved parameters. We believe the present method 
will be useful in clinical applications for hematology. For example, the present method can be used to 
non-invasively assess blood preservatives or the functionalities of stored blood. Using the recently 
developed quantitative phase imaging units (21, 30) and a simple illumination scheme (50), existing 
optical microscopes in a laboratory can be converted into quantitative phase microscopy, which can 
possibly extend the applicability of the present method. Furthermore, the optical measurements of RBC 
parameters presented in this paper can be combined with flow cytometry techniques and fast 3-D 
tomographic measurements (20) such that individual RBCs can be sorted according to their parameters. 
 
Materials and Methods  
Ethics statements and Blood sample preparation Human blood studies were conducted according to 
the principles of the Declaration of Helsinki and were approved by the responsible ethics committee of 
Eulji University Hospital (IRB project number: 2012-0128, Daejeon, Republic of Korea). Blood 
samples from a healthy adult was obtained via regular course of patient care after approval in 
accordance with the procedures of IRB for the remaining blood. Blood was collected into EDTA treated 
anticoagulant tube and divided into two tube. In one of tubes, CPDA-1(citrate-phosphate-dextrose with 
adenine, C4431, Sigma-Aldrich, U.S.A.) was added into whole blood with 1:9 v/v ratio. The other tube 
without CPDA-1 was kept for control sample. Both two tubes were stored at 4°C and agitated 
occasionally. Every few days up to 41 days, the blood from each tubes were tested for quality check 
using 3-D optical tomography. All experimental protocol were proved by the institutional review board 
of KAIST (KH2013-22). For optical measurement, blood was further diluted 300 times in Dulbecco's 
PBS buffer (Gibco®, New York, U.S.A.). 
 
Common-path diffraction optical tomography (cDOT) The Common-path diffraction optical 
tomography is a 3-D QPI technique that can measure the 3-D distribution of RI of individual cells (24, 
51). As an illumination source, a diode-pumped solid state laser (λ = 532 nm, 50 mW, Cobolt, Solna, 
Sweden) was used. The sample, diluted blood sandwiched between two cover glasses with 25×50 mm 
(C025501, MATSUNAMI GLASS Ind., LTD., JAPAN), is placed between the condenser lens 
(UPLSAPO 60×, numerical aperture (N.A.) = 0.9, Olympus, Japan) and objective lens (UPLSAPO 60×, 
N.A. = 1.42, Olympus, Japan).  
For 3-D RI tomography, the optical fields obtained with various incident illumination angles were 
measured by employing the common-path laser-interferometric microscopy (22, 24, 51). By rotating a 
two-axis galvanometric mirror (GVS012/M, Thorlabs, USA), incident angles of illumination beams to 
a sample is controlled. The second galvanometer mirror reflected the beam from a sample to have the 
same optical path regardless of incident illumination angles.  
Holograms of the sample were recorded, employing the principle of common-path interferometry 
(39, 42). After the second galvanometer mirror, a diffraction grating (92 grooves mm-1, #46-072, 
Edmund Optics Inc., NJ, U.S.A.) spatially split the scattering beams and then, spatially filtered 0th order 
beam as a reference was interfered with the 1st order beam as a sample beam. Then, the interferograms 
were recorded on high-speed sCMOS camera (Neo sCMOS, ANDOR Inc., Northern Ireland, UK) while 
the incident beam was scanning spirally with 300 different angles. The total magnification was 240 by 
an additional 4-f system. Then, optical field images, containing both the amplitude and phase maps, of 
the sample were retrieved using a phase retrieval algorithm (12). From the retrieved optical fields, 3-D 
RI distribution of sample was reconstructed using optical diffraction tomography algorithm. Detailed 
information about the reconstruction algorithm can be found elsewhere (22, 31). 
 
Analysis of the red cell parameters From the measured 3D RI tomograms and the 2D dynamic 
membrane fluctuations, six red cell parameters are retrieved, including morphological (cell volume, 
surface area and sphericity), chemical (Hb content and Hb concentration), and mechanical (membrane 
fluctuation) parameters (25, 34, 35, 56). To measure the morphological parameters, we used the 
reconstructed 3-D RI maps (25). The whole volume of a RBC was calculated by integrating all voxels 
inside individual RBCs. The space corresponding to the cytoplasm of a RBC was selected by RI with a 
higher value than the threshold. The threshold was defined by 50% of RI difference between the 
maximum RI of the cell ncell_max and surrounding medium nm for determine the cell boundary, i.e. nthresh 
= nm + 0.5∙ (ncell_max - nm). Then, the total number of voxels was multiplied by the magnification of the 
optical system to translate in a length scale. Next, for the surface area measurements, the isosurfaces of 
individual RBCs were reconstructed from the volume data of the 3-D RI maps. The surface area of the 
isosurface was measured with the sum of the areas of all the patch faces, which were broken down into 
small triangular pieces. In addition, the sphericity SI, a dimensionless quantity ranging from 0 to 1, was 
obtained as follows: SI = π1/3(6V)2/3/A where V is the volume and A is the surface area (25, 52, 55). 
To obtain Hb content of individual RBCs, the measured 2-D phase at the normal angle was used. 
The Hb content of a RBC was obtained from integrating the 2-D optical phase over the entire cell area 
and with the RI increased of the Hb proteins, given as follows: Hb content = (λ/2πα)∫∆φ(x,y)dA, where 
λ is the wavelength of the illumination laser light (532 nm), α is the RI increment (0.2 mL/g) (11, 44), 
and Δφ(x,y) is 2-D optical phase. In addition, the Hb concentration in a RBC was obtained from the Hb 
content divided by the cellular volume (19, 40).  
The dynamic membrane fluctuations in RBCs can be quantitatively and precisely measured using 
cDOT (24, 43). Dynamic full-field optical phase images of a RBC ∆φ(x, y, t) can be measured with a 
normal-angle laser illumination, from which dynamic height maps of the RBC can be calculated as, h(x, 
y, t) = [λ/(2π⋅∆n)]∆φ(x, y, t), and ∆n = 〈n(x, y, z)〉 - nm is a difference between the mean RI of RBC 
cytoplasm 〈n(x, y, z)〉 and surrounding buffer medium nm. 
   The representative cell height images of individual cells in each groups are calculated as the 
temporally averaged cell heights, hm(x, y) = 〈h(x, y, t)〉, and are presented in Figs. 3A & C. To measure 
the mechanical parameter, we calculated the dynamic membrane fluctuation from the successively 
measured instantaneous height map h(x,y;t), given as, h(x,y;t) = [λ/(2π⋅∆n)] ∆φ(x,y;t).The values for 
the membrane fluctuation were calculated by averaging the root-mean-square of the height 
displacement over the cell area, given as: ∆h(x,y) = 〈[h(x,y;t) − hm(x,y)]2〉1/2, where hm is the time 
averaged height at the cell surface. 
 
ACKNOWLEDGEMENTS 
This work was supported by KAIST-Khalifa University Project, APCTP, the Korean Ministry 
of Education, Science and Technology, and the National Research Foundation 
(2012R1A1A1009082, 2014K1A3A1A09063027, 2013M3C1A3063046, 2012-M3C1A1-
048860, 2014M3C1A3052537).  
 
AUTHOR CONTRIBUTIONS 
H.P., S.J. and Y.P. developed the experimental idea. H.P., Y.L. and K.K. performed the experiments and 
analyzed the data. M.J., Y.S. and S.J. prepared blood samples. Y.S., S.J., and Y.P. supervised the study.  
All authors discussed the experimental results and wrote the manuscript. 
 
COMPETING FINALCIAL INTERESTS 
The authors declare no competing financial interests. 
  
 References 
Figures with legends 
 
Fig. 1 Cross-sectional slices of reconstructed RI tomograms of stored RBCs without CPDA-1 as the 
control (A1-A7) and with CPDA-1 (C1-C7) at days 1, 5, 13, 20, 27, 34, and 41 of the storage period, 
respectively, in the x-y (left), y-z (right), and x-z (below) plane (B1-B7 and D1-D7). Corresponding 
rendered isosurfaces of 3-D RI maps for the control and CPDA-1, respectively (n > 1.360).  
 
Fig. 2 Morphological red cell indices of the stored RBCs without CPDA-1 as the control (A, C and E) 
and with CPDA-1 (B, D, and F) at days 1, 5, 13, 20, 27, 34 and 41 of the storage period. (A&B) Cell 
volumes. (C&D) Cell surface areas. (E&F) sphericities. Each symbol corresponds to an individual RBC 
measurement. The horizontal solid line is the mean value with an error bar showing the standard 
deviation. 
 Fig. 3 Representative 2-D topographical images of stored RBCs without CPDA-1 as the control (A1-
A7) and with CPDA-1 (C1-C7) at days 1, 5, 13, 20, 27, 34, and 41 of the storage period (left to right), 
respectively. (B & D) Corresponding membrane fluctuation maps. 
 
Fig. 4 Mean membrane fluctuations of individual stored RBCs without CPDA-1 as the control (A) and 
with CPDA-1 at days 1, 5, 13, 20, 27, 34, and 41 of the storage period. 
 
Fig. 5 Correlation maps between sphericity and mean membrane fluctuations of (A) stored individual 
RBCs without CPDA-1 and (B) with CPDA-1 at days 1, 5, 13, 20, 27, 34, and 41 of the storage period. 
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 Fig. 6 Hb content and concentration in the stored RBCs without CPDA-1 as the control (A and C) and 
with CPDA-1 (B and D), respectively, at days 1, 5, 13, 20, 27, 34, and 41 of the storage period. 
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